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Recently, we found that natural IgG (nIgG; a non-specific immunoglobulin of adaptive immunity) is not
quiescent, but plays a crucial role in immediate immune defense by collaborating with ficolin (an innate
immune protein). However, how the nIgG and ficolin interplay and what factors control the complex
formation during infection is unknown. Here, we found that mild acidosis and hypocalcaemia induced by
infection- inflammation condition increased the nIgG:ficolin complex formation. Hydrogen-deuterium
exchange mass spectrometry delineated the binding interfaces to the CH2–CH3 region of nIgG Fc and
P-subdomain of ficolin FBG domain. Infection condition exposes novel binding sites. Site-directed
mutagenesis and surface plasmon resonance analyses of peptides, derived fromnIgG and ficolin, defined the
interacting residues between the proteins. These results provide mechanistic insights on the interaction
between two molecules representing the adaptive and innate immune pathways, prompting potential
development of immunomodulatory/prophylactic peptides tunable to prevailing infection conditions.
I
n order to combat pathogens, the host has evolved an elaborate immune system comprising of two arms: innate
and adaptive1, which are conventionally known to act in a biphasic manner. Although appearing separate and
sequential, the interaction between proteins of the innate and adaptive immune pathways has been shown to
shape the adaptive immune response2. For example, mannose binding lectin (MBL, a soluble innate immune
PPR) binds to adaptive immune molecules such as antigen-specific IgG in immune complexes3, antigen-specific
IgM4 and secretory IgA5, to facilitate the clearance of the opsonized microbes through activation of the
complement pathway and prime the subsequent adaptive response. However, little is known about the molecular
mechanisms by which adaptive immunity may fine-tune the innate immune responses, since the latter is deemed
to be the frontline defense. The potential interactions between the proteins of the adaptive and innate arms of
immunity remain an important area to be explored.
In contrast to the well-known antigen-specific antibodies that are produced specifically during the adaptive
immune response to an infection, there is a pool of non-specific naturally occurring antibodies comprising of
IgM, IgG and IgA subtypes, which exists prior to an external infection. Amongst the natural antibody isotypes, the
natural IgM has been most well-studied. The natural IgM was shown to possess non-specific avidity for patho-
gens, by virtue of its pentameric structure6,7, which enables it to exhibit a protective effect during infections8,9.
Natural IgG (henceforth referred to as nIgG) belongs to the IgG3 subclass. Although nIgGmakes up the majority
of the serum natural antibodies10,11, the significance of its existence and function remained unexplored. Recently,
Panda et al12 showed that nIgG (deemed to be an adaptive immune protein) collaborates withmajor serum lectins
like ficolin and MBL, to immediately elicit host defense. It was demonstrated that nIgG specifically collaborates
with ficolin (a pattern recognition receptor belonging to the lectin family of soluble PRRs) that is pre-bound to the
pathogen, resulting in effective recognition and opsonization of the invading pathogen. The resulting nIgG:ficolin
immune complex bound on the pathogen evokes innate immune defense, clearing the pathogen through FccR1-
mediated phagocytosis. The H-ficolin was shown to be the most effective of the ficolin isoforms. Further in vivo
studies demonstrated the protective role of nIgG. Mice lacking nIgG showed significantly higher bacterial
burdens in the tissues, delay in bacterial clearance, increased pro-inflammatory and lowered anti-inflammatory
cytokine production and compromised survival post-infection. Reconstitution with nIgG restored nIgG:ficolin
mediated bacterial recognition and clearance and improved survival12. These findings prompted us to probe the
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In this study, we explored the interaction between the nIgG andH-
ficolin under simulated physiological (pH 7.4, 2.5 mM calcium) and
infection-inflammation (pH 6.5, 2.0 mM calcium) conditions. We
showed that the Fc domain of nIgG specifically interacts with the
FBG domain of ficolin. We further delineated the specific binding
interfaces and peptides involved in interaction under normal and
infection-inflammation conditions. Specific arginine and lysine resi-
dues were identified to be responsible for regulating basal interaction
under normal condition, whereas histidine appeared to be crucial in
increasing the affinity of nIgG:ficolin interaction under the infection-
inflammation condition. Our results reveal novel insights into how
adaptive immunity shapes innate immunity through molecular
crosstalk between the proteins of the two arms of immunity.
Identification of the cognate interactive peptides prompts future
development of immunomodulators, which are tunable by pH and
calcium changes in the microenvironment of infection.
Results
Natural IgG complexes with ficolin to recognize bacteria during
infection. Recently, we found that nIgG (belonging to the IgG3 sub-
class), present in the uninfected serum and deemed to be inactive10,11,
actually plays an important role in the immediate microbial
recognition and clearance. It does so with the aid of ficolin12. This
was further supported by specific interactions occurring between
representative nIgGs (human anti-alpha gal IgG13 and IgG3 from
T-cell deficient mice14) and pathogen-associated ficolin. This novel
finding of an adaptive immune molecule collaborating with innate
immune proteins and contributing to an immediate immune defense
sheds light on the underestimated role of natural antibodies, and
prompted us to further examine the nIgG:ficolin interaction
during infection12,15. We found that nIgG alone (purified from the
sera of previously uninfected mice) could not recognize Pseudo-
monas aeruginosa (Fig. 1a). However, nIgG was recruited signifi-
cantly and in a dose-dependent manner in the presence of serum
depleted of IgG (IgG2 serum). This indicates that other serum factors
probably facilitated the bacterial recognition ability of nIgG. Since
our recent study revealed ficolin to be an important player in
enabling bacterial recognition by nIgG12, we further depleted
ficolin from the IgG2 serum and found that nIgG recruitment to
the bacteria was significantly reduced, suggesting that ficolin is a
crucial serum factor, which enables nIgG deposition on the
bacteria (Fig. 1a).
Next, we tested the uptake of the bacteria opsonized by
nIgG:ficolin immune complexes, by monocytes. Our earlier study
showed that amongst all the ficolin isoforms (L-, H- and M-ficolin)
tested, H-ficolin enabled maximal uptake of nIgG opsonized bac-
teria12. Hence, we focused on the biological effects of nIgG:H-ficolin
complex-opsonization of the bacterial mimic (GlcNAc-beads). N-
acetyl glucosamine (GlcNAc) is a pathogen-associated molecular
pattern (PAMP) specifically recognized by ficolin. We found that
GlcNAc-beads opsonized with H-ficolin alone were not recognized
by the U937 monocytes. However, pre-incubation of the GlcNAc-
beads with nIgG and H-ficolin led to efficient opsonization and
co-localization of the nIgG:H-ficolin immune complex on themono-
cytes (Fig. 1b).
Infection-induced inflammation is known to cause a drop in
pH16–18 and calcium19–21 levels in the serum at the microenvironment
of the infection site. This is known to boost the interaction between
the immune proteins and subsequent anti-microbial response22. This
prompted us to explore the extent of nIgG:H-ficolin interaction
under simulated physiological condition (pH 7.4 and 2.5 mM
Ca21) and infection-inflammation condition (pH 6.5 and 2 mM
Ca21). For this purpose, we used specific buffers previously estab-
lished by others who also used these conditions to study protein:pro-
tein interaction in innate immune response22–24. To support our
observation of nIgG:H-ficolin immune complex formation
(Fig. 1b) we enumerated the immune complexes formed under the
normal and infection-inflammation conditions by using proximity
ligation assay (PLA) to demonstrate the nIgG:H-ficolin interactions
in situ. Upon incubating the monocytes with the nIgG:H-ficolin
opsonized GlcNAc-beads, we observed a significant increase in the
number of complexes (each red dot signifies a complex) under the
infection-inflammation condition as compared to the normal con-
dition (Fig. 1c, d). These results highlight the importance of the
molecular interaction between nIgG and H-ficolin (wherein ficolin
is pre-bound to the bacteria), and emphasize the bridging action of
nIgG in bringing the H-ficolin-bound bacteria to the monocytes for
clearance. The marked increase in the nIgG:H-ficolin immune com-
plex formation under infection-inflammation condition also sug-
gests that this immune response is specific, biophysically stable
and ensures no random over-activation of the immune reaction,
although a basal level of nIgG:ficolin immune complex formation
occurs under normal condition.
nIgG:ficolin immune complexes are increased by infection. After
ascertaining that nIgG:ficolin immune complexes direct the
opsonized bacteria to the monocytes in vitro, we explored whether
nIgG:ficolin complexes are formed in vivo in mice, post-infection.
We observed an increase in the nIgG:ficolin complexes in a time (0–
24 hours post-infection, hpi)- and dose (106–107 cfu)- dependent
manner (Fig. 2a) in the serum of mice infected with Pseudomonas
aeruginosa. As immune complexes are known to be targeted to the
spleen to prevent the spread of infection to other vital organs25, we
checked for presence of nIgG:ficolin complexes in the spleens of
infected mice. A corresponding increase in nIgG:ficolin complexes
was observed in a dose- and time- dependent manner (Fig. 2b),
concurrent with the increase in complex formation observed in the
serum (Fig. 2a). This further supports the stability of the nIgG:ficolin
complexes and their pathophysiological significance.
To gain further insights into the mode of nIgG:ficolin interaction,
we characterized and delineated the dynamics of nIgG:ficolin inter-
action. Since there are three isoforms of ficolin, each comprising a
collagen-like domain26,27 and a fibrinogen-like domain (FBG), which
recognizes PAMPs like GlcNAc, it was pertinent for us to check the
interaction of nIgG with all three ficolin isoforms. By yeast 2-hybrid
assay, we observed that nIgG interacted with all three ficolin iso-
forms, showing strongest interaction with H-ficolin (Fig. 2c). We
observed higher binding preference between nIgG and H-ficolin.
The CH2–CH3 subdomain of nIgG Fc interacts with the P-sub-
domain of ficolin FBG. Next, we characterized the domain-specific
interaction between nIgG and ficolin by studying the subdomain-
specific interaction of the two proteins in comparison with their
respective full-length proteins. We observed that nIgG Fc region
interacts with the FBG domain of ficolin (Fig. 3a). The negative
controls showed no interaction, ascertaining the specificity of nIgG
Fc:ficolin FBG interaction. We found that nIgG purified from
uninfected human serum (Supplementary fig. 1a, b) bound dose-
dependently to the ficolin FBG domain immobilized on GlcNAc-
BSA (Fig. 3b). In particular, significantly stronger binding between
nIgG and ficolin FBG was observed under infection-inflammation
condition (Fig. 3b).
Since we have delineated the nIgG:ficolin interaction to the Fc
region of nIgG and the FBG domain of ficolin (Fig. 3), and that the
infection-inflammation condition increases the nIgG:ficolin com-
plex formation (Fig. 3b), it was imperative to locate their precise
binding interfaces under normal and infection-inflammation condi-
tions to gain further insights into the dynamics of interaction during
an infection.Wemapped the interaction sites using amide hydrogen-
deuterium exchange coupled with mass spectrometry (HDMS). A
reduction in deuterium incorporation in the presence of a protein
partner indicates that the corresponding specific peptide sequence is
involved in the interaction surface28,29. The differential incorporation
www.nature.com/scientificreports
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Figure 1 | Natural IgG collaborates with ficolin to recognize bacteria and form immune complexes on monocytes. (a) FACS analysis to detect nIgG
bound to 106 cfu P. aeruginosa opsonized with proteins (see key below the figure) and incubated with primary anti-mouse IgG3, followed by staining with
Alexa488-conjugated secondary antibody. nIgG purified from undepleted pooled sera of uninfected mice (n 5 8) does not bind to P. aeruginosa (red). It
binds to the bacteria only when aided by dose-dependent increase in IgG2 serum (1520; blue and 1510; orange). Further depletion of ficolin from the
IgG2 serum (1510 ficolin2 IgG2 serum; green) shows reduction in binding of nIgG to P. aeruginosa. nIgG binding decreases when bacteria were incubated
with 1510 ficolin2 serum (light grey) as compared to 1510 undepleted serum (dark grey), indicated by the shift (arrow). The right panel shows
quantitative comparison of the FACS plots of different samples indicated by mean fluorescence intensity (MFI) of nIgG binding. (b–d) U937 monocytes
were incubated with GlcNac-beads opsonized with H-ficolin, nIgG or the nIgG:ficolin complex. (b) Confocal microscopy to detect co-localization of
nIgG (green) and ficolin (red) on the monocytes, which were pre-incubated for 30 min at room temperature with GlcNAc-beads opsonized with H-
ficolin, nIgG or the nIgG:H-ficolin complex. The cell nuclei were stained with DAPI (blue). 633 objective; scale bar, 5 mm. (c) In situ proximity ligation
assay (PLA) to identify nIgG:ficolin interaction under normal and infection-inflammation conditions on the monocytes, using anti-human IgG3 and
anti-H-ficolin antibodies. Protein-protein interactions are seen as PLA signals – each red dot represents an interaction. 633 objective; scale bar, 5 mm.
(d) Quantification of the number of PLA signals of nIgG:H-ficolin complex. The interaction complexes per cell were scored using Image J software.
Duplicates of 50 cells eachwere enumerated for each condition tested. Three replicates per condition were tested and three independent experiments were
performed. *p , 0.05; **p , 0.01; n.s., not significant.
www.nature.com/scientificreports
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of deuterium for each peptide was calculated across all time points of
interaction.
We determined the contact surfaces on the nIgG molecule when
complexed with H-ficolin. The nIgG peptides: DTLMISRTPEV-
TCVV278–292, VLHQDWLNGKE337–347 and LTCLVKGFYPSDI394–406,
corresponding to the CH2–CH3 interface in the Fc region showed
decreased deuterium incorporation in the presence of H-ficolin
(Fig. 4a [i] and 4b). The non-binding nIgG peptides, which show
no difference in deuterium incorporation in the presence or absence
of H-ficolin, are the negative control peptides (Fig. 4a [ii]). When we
compared the extent of deuterium incorporation in H-ficolin alone
and H-ficolin incubated with nIgG under normal condition, we
found three interacting peptides in the P subdomain of ficolin FBG
domain: YRAGFGNQESEFWLGNENLHQ150–170, AHYATFRL-
LGEVDHYQL193–209 and NGRYAVSEAAAHKYGID264–280, which
showed marked differences in deuterium incorporation when in
complex with nIgG (Fig. 4c [i] and 4d). These observations are
consistent with the ELISA results (Fig. 3b), which also indicated that
ficolin FBG harbors the binding sites for nIgG.
Interestingly, an additional H-ficolin peptide, YDADHDSSNS
NC234–245 (Fig. 4c [i] lower panel), also in the P subdomain of FBG,
showed decreased deuterium uptake under the infection-inflam-
mation condition. This supports our postulate that an infection-
induced reduction in pH may expose additional sites in the ficolin
for the nIgG to bind to, and it also supports the 100-fold increase in
affinity between nIgG and H-ficolin FBG under infection-inflam-
mation condition12. In addition under the infection-inflammation
condition, the nIgG:H-ficolin complex exhibited four FBG peptides
spanning residues PRNCRELLS90–98, YHLCLPEGR107–115, QRRQDG
SVDFFR134–145 and GVGHPYRRVRMM286–297, each showing in
creased deuterium uptake (Fig. 4c [ii] ), indicating greater solvent
accessibility under reduced pH and calcium conditions. The H-fico-
lin peptides showing no difference in deuterium incorporation in the
presence or absence of nIgG are the non-binding control peptides
(Fig. 4c [iii]).
We also performed computational docking studies between IgG Fc
(PDB code: 1H3Y) and ficolin FBG (PDB code: 2J64) using either
random (Supplementary fig. 2a) or guided docking based on the
HDMS results (Supplementary fig. 2b). The HDMS-guided docking
showed a lower energy score (ZRank score) compared to random
docking (Supplementary fig. 2c), which indicates higher stability and
better probability of complex formation.
Histidine is the critical residue regulating infection-inflammation
induced nIgG:ficolin interaction. Next, to further understand how
perturbation of the micro-environment at the site of infection affects
the nIgG:ficolin interaction (which has implications on how the
adaptive and innate immune systems crosstalk at a molecular
level), we attempted to define the precise binding residues between
nIgG and ficolin. Based on the HDMS results, we synthesized
peptides derived from nIgG and ficolin, and performed surface
plasmon resonance (SPR) analysis to characterize the real-time
interaction between these peptides and their cognate proteins (fico
lin or nIgG, respectively) under normal and infection-inflammation
conditions. We also tested single- and double- amino acid mutant
peptides, where arginine (R), lysine (K) and histidine (H) were
Figure 2 | nIgG:ficolin immune complexes increase post-infection. (a) Immunoblot analysis of total IgG (50 kDa heavy chain) and ficolin levels in the
pooled sera ofmice (n5 8) (top panel) and detection of nIgG (50 kDa heavy chain ofmouse IgG3) and ficolin in nIgG:ficolin complexes (pulled down by
Protein G beads) in serum (boxed in red), post-infection with 106 or 107 cfu P. aeruginosa over time course. The samples were derived from the same
experiment, resolved under 12% reducing SDS-PAGE and the gels and blots were processed in parallel. Representative immunoblots (cropped for
improving clarity and conciseness of presentation) from three independent experiments is shown. Full-length blots are presented in Supplementary
Fig. 4a. (b) Immunofluorescence staining to detect co-localization of nIgG:ficolin complexes (using anti-mouse IgG3 and anti-ficolin) in spleen sections
of WT mice (n 5 3), infected with 106 or 107 cfu P. aeruginosa over time course. 1003 objective. Scale bars, 10 mm. (c) Yeast two-hybrid screening to
detect single chain interaction between nIgG and L-, H- and M-ficolin isoforms. nIgG interacts strongest with H-ficolin (red box).
www.nature.com/scientificreports
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substituted with uncharged alanine (A). We found that the nIgG
peptides, DTLMISRTPEVTCVV278–292 (peptide 1) and LTCLVKG-
FYPSDI394–406 (peptide 6) bound to ficolin on GlcNAc-chip with
similar affinity (KD , 1026 M) under both normal and infection-
inflammation conditions (Fig. 5). However, the binding was
abolished by a point mutation of R (peptide 2) or K (peptide 7) to
an uncharged A residue. Moreover, a mutation fromH-A (VLAQD-
WLNGKE, peptide 4) abolished the interaction between this nIgG
peptide and ficolin at pH 6.5. The wild type peptide (VLHQD-
WLNGKE337–347, peptide 3) and the K-A substitution mutant
(VLHQDWLNGAE, peptide 5), both interacted with ficolin at high-
er affinity under infection-inflammation condition as compared to
the normal condition, indicating that K346 is not a critical residue
involved in interaction. Taken together, our results suggest that the
interaction between nIgG:ficolin is controlled by electrostatic forces
between charged side chains of amino acids - Arg and Lys regulate a
basal level of interaction under normal condition whereas, Arg, Lys
and His regulate interaction under infection-inflammation condi-
tion. The mutant nIgG peptides (2,4,5,7) did not bind to ficolin
under both normal and infection-inflammation conditions.
Sensorgrams for peptides 3 and 5, tested under normal condition,
are shown as representative non-binding SPRplots. On thewhole, we
have found that multiple positively charged side chains of Arg and
Lys contributed to basal binding affinity under normal condition,
while His339 specifically contributed to higher affinity under infection-
inflammation condition (Fig. 5).
nIgG peptides block the formation of nIgG:ficolin complex under
infection condition. Next, we examined whether the peptides
derived from nIgG would affect nIgG:ficolin complex formation
under infection condition. To achieve this, we first tested the bind-
ing of nIgG to ficolin bound to GlcNAc in the absence or presence of
increasing doses of three ‘‘ficolin-binding nIgG peptides’’ (an
equimolar mixture of DTLMISRTPEVTCVV278–292, VLHQDWLN-
GKE337–347 and LTCLVKGFYPSDI394–406 in 151 or 551 molar ratio of
nIgG peptides to ficolin). We also compared nIgG:ficolin complex
formation in the presence of non-binding mutant nIgG peptides
(DTLMISATPEVTCVV278–292, VLAQDWLNGKE337–347 and LTCL-
VAGFYPSDI394–406) as a control. Figure 6a shows successive reduc-
tion in the levels of nIgG bound to ficolin when co-incubated with
Figure 3 | nIgGFc interacts with ficolin FBG– infection-inflammation condition increases IgG:ficolin complex formation. (a) Delineation of the single
chain interaction domains of nIgG and H-ficolin by yeast two-hybrid. The full-length and Fc region of nIgG and the full-length, FBG and collagen-like
domain ofH-ficolin were individually subcloned into the bait and prey vectors. To compare the strength of interaction, yeast colonies were serially diluted
and plated on QDO plates. Either in bait or prey vectors, nIgG Fc exhibited strongest interaction with FBG domain of H-ficolin (red boxes). (b) ELISA to
detect binding of nIgG purified from uninfected human serum to recombinant L-, H- and M-ficolin FBG bound on immobilized GlcNAc-BSA under
both normal (white bar) and infection-inflammation (black bar) conditions. Firstly, ficolin FBGwas incubated with immobilized GlcNAc-BSA, followed
by increasing doses of purified IgG. nIgG bound was detected using anti-human IgG3 and corresponding HRP-conjugated secondary antibody.
Absorbance (OD) was read at 405 nm. Three replicates per condition were tested and three independent experiments were performed. *p , 0.05;
**p , 0.01; n.s., not significant.
www.nature.com/scientificreports
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Figure 4 | Identification of binding interfaces between nIgG and H-ficolin by HDMS. (a) and (c) HDMS to identify interaction sites between (a) nIgG
and (c) H-ficolin. Deuterium incorporation in proteins over time is annotated as follows: solid lines, presence of both nIgG and H-ficolin; dashed lines
(control), presence of either nIgG or H-ficolin; black lines, normal condition; and orange lines, infection-inflammation condition. The amino acid
sequence of the peptides is indicated in each panel. 18 and 16 peptides, respectively, of nIgG (70% coverage) and H-ficolin (85% coverage) were selected
for plotting the graphs based on themass spectrometric peak quality. Binding peptides of nIgG andH-ficolin showing decreased deuterium incorporation
in the presence of both the proteins as compared to individual protein under both conditions, in particular under infection-inflammation condition are
indicated by downward orange arrow. H-ficolin non-binding peptides showing increased deuterium incorporation in the presence of both proteins as
compared to H-ficolin alone (under infection-inflammation condition) are indicated by upward orange arrow. Representative non-binding peptides
showing no difference in deuterium incorporation in the presence of individual proteins or both proteins serve as negative controls. The structure
diagrams indicate (b) nIgG Fc and (d) H-ficolin FBG, highlighting the interacting peptides in orange. The additional H-ficolin peptide
(YDADHDSSNSNC234–245) interacting with nIgG only under the infection-inflammation condition is highlighted in pink. Results aremean6 S.D. from 3
independent experiments.
www.nature.com/scientificreports
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Figure 5 | Binding affinity and identification of contact residues of nIgG peptides with ficolin. Surface plasmon resonance (response unit) to
characterize the binding affinities between nIgG peptides and H-ficolin, under normal and infection-inflammation conditions. GlcNAc-BSA was
immobilized on the CM5 chip to expose GlcNAc as a ligand for anchoring ficolin to the chip. H-ficolin (200 nM) was first injected over GlcNAc,
respectively for 100 s (association time) followed by buffer flow (wash) for 200 s (dissociation time). Increasing concentrations of nIgG peptides (5, 10, 20
and 50 mM) were injected over the H-ficolin bound to the chip, under similar conditions. Mutant peptides (with Arg, Lys or His substituted to Ala) did
not bind to the corresponding proteins. Human serum albumin (HSA) injected after H-Ficolin served as a negative control (blue, see top 2 panels). nIgG
peptides (WTormutants) are tabulated below the respective graphs. Peptides, injected directly over theGlcNAc-immobilized chip as controls, showed no
binding to GlcNAc (blue). Data were analyzed using BIAevaluation software 3.2. The binding curves (black) are overlaid with the fit of 151 interaction
model (red). The plots are a typical representation of 3 independent experiments.
www.nature.com/scientificreports
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increasing doses of the ‘‘ficolin-binding nIgG peptides’’. This is likely
due to the competition between the ‘‘ficolin-binding IgG peptides’’
and whole nIgG to bind to ficolin. We still observed a significant
increase in nIgG:ficolin complex formation under infection-
inflammation condition compared to normal condition, with or
without nIgG peptides. Since not all nIgG binding sites on the
ficolin molecule are occupied by the peptides, it is conceivable that
nIgG would bind with higher affinity to the unbound sites on ficolin
under infection-inflammation condition, giving rise to an increase in
nIgG:ficolin complexes. The binding of nIgG peptides to ficolin was
specific since the non-binding nIgG peptides did not affect the
formation of the nIgG:ficolin complex. In the absence of the
bacterial mimic (-GlcNAc, Fig. 6a, bottom panel), no nIgG:ficolin
complex was observed, indicating the specificity of immune complex
formation only in presence of the bacteria.
To show the effects of pre-blocking ficolin in the serum on the
formation of nIgG:ficolin complexes, we incubated the serum with
nIgG peptides (which specifically target ficolin) compared with non-
binding mutant nIgG peptides. Consistent with the ELISA results
(Fig. 6a), we observed a significant reduction in nIgG:ficolin com-
plexes in both human serum and pooled mice serum, when the sera
were pre-treated with increasing doses of ‘‘ficolin-binding nIgG pep-
tides’’ prior to incubating with P. aeruginosa (Fig. 6b). No effect on
the complex formation was observed with sera incubated with con-
trol non-binding nIgG peptides, indicating the specific blocking of
nIgG:ficolin interaction by the ‘‘ficolin-binding nIgG peptides’’.
Recently, Panda et al provided further in vivo support by showing
that the blocking of endogenous ficolin by the ‘‘ficolin-binding nIgG
peptides’’ compromised the nIgG:ficolin immune complex forma-
tion during infection in mice and compromised their survival12.
Taken together, these findings highlight the following: (a) the
importance of specific interaction residues in the nIgG (Fig. 5), which
when mutated, prevents interaction with ficolin, as evidenced by the
inability of the mutant nIgG peptide to block the nIgG:ficolin inter-
action (Fig. 6b); (b) no nIgG:ficolin complexes were formed without
infection, ascertaining the specificity of immune complex formation
only upon infection to avoid random over-activation; (c) the signifi-
cance of ficolin as a partner of nIgG, in facilitating the adaptive-
innate immune crosstalk.
nIgG:ficolin immune complexes are formed independently of
C1q. It is known that after IgG has formed immune complexes,
C1q (a classical complement pathway activator) interacts with all
isoforms of IgG at the CH2 domain of Fc, involving the residues:
Glu 318, Lys 320 and Lys 32230. This IgG-C1q interaction then
activates the classical complement pathway. Here, we have found
that H-ficolin interacts with the CH2-CH3 domain interface of
IgG (Fig. 4a, b). Next, we queried the potential involvement of C1q
in the nIgG:ficolin immune complex formation. We first performed
computational docking of known crystal structure of C1q on IgG Fc
and observed that the binding site of C1q on IgG Fc (Supplementary
fig. 3a) was consistent with previous finding30. Next, to test whether
C1q and ficolin compete for binding to IgG during the immune
complex formation, we superimposed the docking structures of
C1q:IgG Fc (Supplementary fig. 3a) and of H-ficolin FBG:IgG Fc
(Supplementary fig. 2b) on each other, and found that C1q and H-
ficolin bind at different sites on IgG (Supplementary fig. 3b). Hence,
C1q and ficolin may not compete with each other for IgG.
To further support the computational predictions, we tested the
binding of C1q to immobilized nIgG (anti-alpha gal IgG from unin-
fected human serum) in the absence or presence of increasing doses
of H-ficolin and vice versa. We found that C1q and H-ficolin were
able to bind to nIgG to the same extent, independent of each other
(Supplementary fig. 3c), further corroborating that C1q and ficolin
bind to different sites on IgG Fc. Next, we tested whether C1q enables
nIgG deposition on the bacterial mimic (GlcNAc beads) and if so,
how it might influence the immune complex formation. We incu-
bated the GlcNAc beads with H-ficolin or nIgG or C1q or a com-
bination of these proteins, and observed that H-ficolin, which was
bound to the bacterial mimic, did not recruit C1q, hence showing
that C1q and H-ficolin did not interact. We found that C1q was
recruited only after the nIgG:H-ficolin immune complex had formed
and it did not influence the nIgG:ficolin mediated recognition of the
bacterial mimic (Supplementary fig. 3d). This finding is consistent
with reports that have shown that C1q is recruited by immobilized
natural IgM after it had formed immune complexes9,26. Overall, these
results indicate that C1q is not involved in nIgG:ficolin bacterial
recognition and immune complex formation (Supplementary
fig. 3e).
Discussion
Collaboration between the two arms of immunity, wherein innate
immunity directs the adaptive immune response, has been estab-
lished as an important phenomenon in host defense against infec-
tion. Innate immune PRRs induce signals at multiple checkpoints2,31
to dictate the initiation and control of the adaptive immune res-
ponse. This is influenced by several parameters such as the origin
and dose of the antigen, which impacts the type, magnitude and
duration of the immune response and the production of long-term
memory. Even though studies have shown that innate immunity
shapes adaptive immunity, it is unclear whether and how the adapt-
ive immune system affects the innate immune response. Our recent
discovery that nIgG is not passive but plays an essential protective
role during early infection by associating with ficolin bound to the
pathogen12, construes that an adaptive immune protein shapes the
innate immune response. Here, we elucidated the biochemical and
biophysical interaction between nIgG:ficolin and precisely mapped
the functional domains and residues of contact between the two
proteins.
We demonstrated increased nIgG:ficolin complex formation
under mild acidosis and hypocalcaemia, which prevail at the site of
infection. Studies with innate immune proteins have also highlighted
similar higher affinity interactions under infection-inflammation
condition22, which leads to a synergistic immune response.
Infection-induced reduction in pH is known to cause conformational
changes in ficolin by exposing additional binding sites and enhan-
cing its interaction with the acute phase protein, CRP32,33. Themodu-
lation of the immune response by varying pH and calcium levels
suggests that the host makes use of these perturbations to regulate
the pathogen recognition, immune complex formation and sub-
sequent pathogen clearance. This phenomenon is crucial for the
specificity of a pathogen-driven immune defense, precluding ran-
dom immune response, which would otherwise result in autoimmu-
nity. Importantly, we have revealed the precise sites of interaction
between the two components of the adaptive and innate immune
pathways under infection condition. Notably, we found an additional
interaction binding site (YDADHDSSNSNC234–245) in the ficolin
which became exposed for interaction with nIgG under reduced
pH and calcium levels, with a 100-fold increase in binding affinity
(Fig. 5), possibly supporting the increase in the nIgG:ficolin complex
formation. We also delineated the exact binding residues of IgG that
interact with ficolin, and found that specific Arg (R284) and Lys (K346
andK399) residues regulate the basal level of interaction under normal
condition, whereas His (H339) seems to be crucial in regulating the
nIgG:ficolin interaction under infection condition. Other reports
have also documented His to be a regulator of interaction between
immune proteins under physiological and pathophysiological con-
ditions33. At the pH of infection-inflammation condition used in our
study, it is likely that the His side-chains undergo a change in their
protonation states and adopt a more positive character at reduced
pH. This change would be expected to impact the polar/ionic inter-
actions between the two proteins and increase their affinity under the
www.nature.com/scientificreports
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infection-inflammation condition. Additionally, we speculate that
infection-induced conformational change in the ficolin FBG domain
exposes extra sites to the solvent, which did not bind nIgG, but may
engage with other serum proteins during infection. This would
ensure interaction between multiple immune proteins to stage an
optimal response against pathogens.
The ability of the host immune system to modulate the protein:-
protein interactions by changes in the side-chain charge of amino
Figure 6 | nIgG peptides (that bind ficolin) block nIgG:ficolin complex formation during infection. (a) ELISA to detect binding of nIgG to H-ficolin
pre-bound on immobilized GlcNAc under both normal and infection-inflammation conditions with or without prior incubation with nIgG binding and
non-binding peptides to ficolin. Firstly, H-ficolin was incubated with immobilized GlcNAc-BSA (1GlcNAc), followed by increasing doses of nIgG
peptides (non-binding or binding) in 151 or 551 molar ratio to H-ficolin. Then, 1510 diluted ficolin-depleted serum was added and nIgG bound was
detected using anti-human IgG3 and correspondingHRP-conjugated secondary antibody. BSA immobilized instead of GlcNAc-BSA (-GlcNAc) served as
a negative control. Absorbance (OD) was read at 405 nm. Three replicates per condition were tested and three independent experiments were performed.
*p , 0.05; **p , 0.01; n.s., not significant. (b) Immunoblot to detect nIgG (50 kDa heavy chain of IgG3) and ficolin (37 kDa; human and 35 kDa;
mouse) in nIgG:ficolin complexes (pulled down by Protein G beads) in human serum and pooled mice sera (n 5 8) upon incubation with P. aeruginosa
(P.a.) for 30 min at room temperature. Prior to incubationwith the bacteria, the serawere incubatedwith increasing doses of nIgGpeptides (non-binding
or binding to ficolin) for 15 min at room temperature. Sera pre-incubated without or with the peptides (551 molar ratio to ficolin) but without P.a.
incubation, served as controls. The samples were derived from the same experiment, resolved under 12% reducing SDS-PAGE and the gels and blots were
processed in parallel. Representative immunoblots (cropped for improving clarity and conciseness of presentation) from three independent experiments
is shown. Full-length blots are presented in Supplementary Fig. 4b.
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acids indicates immune regulation at the molecular level. In fact, the
nIgG peptides that were found to bind ficolin were able to block
nIgG:ficolin interaction to different extents depending on normal
or infection-inflammation conditions. Hence, it is likely that these
peptides have the potential to be developed into immunomodulators
to treat immune disorders with impaired ficolin levels4,5,34.
Furthermore, the potency of these peptides could be tuned by the
prevailing pH and calcium conditions tomodulate the immune com-
plex formation.
Interestingly, the nIgG:ficolin immune complex formation takes
place in a similarmanner in both humans andmice, although ficolins
from humans and mice differ in some of their physicochemical
properties. Humans have three isoforms (L-, H- and M-), whereas
mice have two isoforms – the mouse ficolins A and B are thought to
be the respective homologues of human L-ficolin35 and human M-
ficolin36. The human H-ficolin is a pseudogene in mice36. However,
we found that during infection, both the human and mice ficolins
bind to the pathogen and recruit nIgG to form an immune complex.
The conservation of this phenomenon across species suggests the
fundamental significance of nIgG:ficolin mediated innate immune
defense.
In our recent study12, we found the important difference between
nIgG (specifically belonging to the IgG3 subclass) and antigen-spe-
cific IgG3. Although both classes belong to the IgG3 subclass, they
differ in the mode of bacterial recognition. Antigen-specific IgG is
well-known to directly recognize and bind to the pathogen due to its
specificity, whereas we found that nIgG requires the help of lectins
like ficolin to recognize the bacteria. Once the immune complex is
formed [bacteria GlcNAc:ficolin:IgG], it is likely that both nIgG and
antigen-specific IgG will activate downstream pathways like
complement activation and phagocytosis. Here, we also found that
the nIgG:ficolin immune complex recruits C1q, which may subse-
quently activate the complement pathway. This novel shortcut
mechanism of anti-microbial defense prompts further exploration
in the field of natural antibodies and their role in immunity.
Methods
Mice. 6–8 week old Balb/c mice were inbred in ‘‘specific pathogen free’’ conditions at
theNUSCARE facility. Gender- and age-matchedmice were used in the experiments.
Systemic infection of the mice was performed intravenously through the tail vein. All
experiments were carried out in compliance with institutional guidelines and
approved by the Institutional Animal Care and Use Committee (IACUC Protocol
Ref: 108/08).
Analyses of protein binding by flow cytometry. P. aeruginosa (PAO1 strain) was
cultured and prepared for the experiment as previously described12,22. To estimate the
binding of purified nIgG to bacteria, the bacteria were incubated with purified mouse
nIgG with or without pooled mice serum depleted of IgG or depleted of both IgG and
ficolin, for 2 h at room temperature, with shaking. The non-specific bound proteins
were removed by washing three times with the wash buffers. Then, the nIgG bound
was detected by staining the bacteria with primary anti-mouse IgG3 (15500) (Sigma),
followed by staining with corresponding Alexa 488-conjugated secondary antibody
(15500) (Invitrogen). Flow cytometric analysis was performed using Dako Cyan
Cytomation LX (Becton Dickinson) and the samples were analyzed using the Summit
V4.3.02 software.
ELISA and Co-immunoprecipitation for analysis of H-ficolin, nIgG and C1q
interactions. ELISAwas carried out as previously described12,22, to test the interaction
between nIgG:H-ficolin in the absence or presence of C1q or nIgG:C1q in absence or
presence of H-ficolin. Information on the source of proteins used in the experiment is
provided in the Supplementary information. Briefly, 1 mg of representative nIgG
(human anti-alpha gal IgG) was immobilized overnight in 96-well MaxisorpTM plate
(NUNC, Denmark) at 4uC, followed by co-incubation with 1 mg H-ficolin and
increasing doses of C1q and vice versa, for 2 h at 37uC. After washing the wells four
times with the wash buffers (TBST for normal condition or MBST for infection-
inflammation condition), C1q or H-ficolin bound to nIgG was detected with
respective primary anti-human C1q (152000) or anti-H-ficolin (153000) antibody
followed by corresponding HRP-conjugated secondary antibody (153000). The
ABTS substrate (Roche Diagnostics, Germany) was added to the wells and incubated
in the dark for 15 min, followed by reading the absorbance at 405 nm.
To test for the immune complex formation between H-ficolin, nIgG and
C1q on the bacterial mimic, GlcNAc beads (bacterial mimic) were incubated with
H-ficolin, nIgG, C1q or a combination of the proteins under normal and
infection-inflammation conditions for 2 h at room temperature. After washing the
beads with thewash buffers, the proteins that had formed the immune complex on the
bacterial mimic were detected by boiling the GlcNAc beads in 13 SDS-PAGE loading
dye, followed by analysis using SDS-PAGE electrophoresis and Western blotting
using specific antibodies.
Immunohistochemistry of spleen sections.Micewere euthanized, and spleen tissues
were procured, washed in PBS and immediately frozen in Jung tissue freezing
medium (Leica Microsystems) using liquid nitrogen, in a similar manner as
previously described12. Tissues were sectioned at a thickness of 5 mm using Leica
Cryostat 1850. For immunohistochemistry, the spleen sections were fixed with 4%
paraformaldehyde and stained with primary antibodies (anti-mouse IgG3 and anti-
ficolin) and respective secondary antibodies. Imaging was done using LSM 510 Meta
confocal microscope.
Cell cultures. The U937 monocytic cell line was cultured in RPMI 1640 (Invitrogen)
supplemented with 10% (v/v) FBS (Invitrogen), 100 IU/ml penicillin and 100 mg/ml
streptomycin (Invitrogen) at 37uC, 5% CO2 condition. HEK293T cells expressing the
recombinant proteins (transfected with the pSecTag2 recombinant vectors) were
cultured in DMEM (Invitrogen) supplemented with 10% FBS, 100 IU/ml penicillin,
100 mg/ml streptomycin and 200 mg/ml zeocin (selection antibiotic).
Simulation of ‘‘normal’’ and ‘‘infection-inflammation’’ conditions in vitro. The
infection-inflammation condition is characterized by a drop in pH from 7.4 to 6.537 at
the infection site. The calcium concentration in the infected tissuemicroenvironment
has also been reported to drop to #2 mM from 2.2 to 2.6 mM in the healthy
condition19–21. Therefore, we simulated ‘‘normal condition’’ (TBS buffer containing
25 mM Tris, 145 mM NaCl, pH 7.4 and 2.5 mM CaCl2) and ‘‘infection-
inflammation condition’’ (MBS buffer containing 25 mM MES, 145 mM NaCl, pH
6.5 and 2 mM CaCl2) using the specific buffers, similar to what has been previously
used by others22–24.
Immunofluorescence staining. For detecting the co-localization of the proteins on
the monocyte surface, U937 monocytes were plated at a density of 0.5 3 106 cells/ml
onto charged coverslips. Then, themonocytes were incubated with theGlcNAc-beads
pre-incubated with proteins for 20 min at 37uC, washed thrice with PBS and fixed
with 4% paraformaldehyde for 15 min at room temperature. Non-specific staining of
the monocytes was blocked by incubating in the blocking buffer (3% BSA in PBS) for
30 min at room temperature. Themonocytes were then incubated with the respective
primary and secondary antibodies diluted in the incubation buffer (3% BSA in PBS
containing 0.05% Tween 20) for 60 min at room temperature and washed thrice with
PBS containing 0.05% Tween 20. The nucleus was stained using Prolong Gold
antifade reagent withDAPI (Invitrogen) present in themountingmedia. Images were
taken by the LSM META 510 confocal microscope (Carl Zeiss) using a 633 oil
objective.
In situ proximity ligation assay. Proximity ligation assay (PLA) was performed to
quantitate the nIgG:ficolin interactions in situ, as described earlier12. Briefly, 0.53 106
U937 monocytes were first plated onto charged cover slips (Sterilin, London, UK).
The monocytes were then incubated with GlcNAc-beads pre-opsonized with H-
ficolin or, nIgG or both the proteins for 20 min at 37uC under simulated normal or
infection-inflammation conditions. Monocytes were washed three times with PBS,
fixed with 4% (w/v) paraformaldehyde in PBS for 15 min, followed by blocking with
10% fetal bovine serum in PBS for 2 h at room temperature. The nIgG:ficolin
complexes were detected using compatible primary antibodies and secondary
antibodies conjugated with PLUS and MINUS oligonucleotide probes [Duolink
detection 563 kit (Olink Biosciences, Uppsala, Sweden)]. The oligonucleotides
present in the two PLA probes hybridize only if they are in close proximity (eg. during
protein:protein interaction). Subsequently, the two hybridized oligonucleotides were
ligated by Duolink ligase, amplified by Duolink Polymerase and detected as red
fluorescent signals using LSM 510 Meta Confocal Laser Scanning microscope (Carl
Zeiss). All images were taken using a 633 oil immersion lens. Samples incubated
without primary antibodies served as experimental negative controls.
Amide hydrogen-deuterium exchange mass spectrometry (HDMS) and data
analysis.HDMS was performed to delineate the interaction interfaces between nIgG
and H-ficolin under normal (pH 7.4) and infection-inflammation (pH 6.5)
conditions. The experimental protocol followed was similar to that described by
Zhang et al32. Briefly 2 ml each of the both the proteins (concentrations approx.
2.5 mg/ml) were mixed with 18 ml of the deuterated buffer at the pH 7.4 or 6.5, in
order to start the hydrogen-deuterium exchange reaction. After incubating the
reactionmixture for different time points (0, 1, 2, 5, or 10 min) to allow the hydrogen-
deuterium exchange, the reaction was quenched by lowering the pH to 2.5 with the
addition of 180 ml of ice-cold 0.1% (v/v) trifluoroacetic acid (Sigma-Aldrich). Then,
100 ml of the quenched reaction mixture was mixed with 50 ml pepsin bead slurry
(Pierce) to enable protein digestion. The pepsin beads were activated by washing
thrice with 0.1% trifluoroacetic acid (pH 2.5) at 4uC. The pepsin-added reaction
mixture was vortexed for 30 s and incubated on ice for 30 s, and this cycle was carried
out for 5 min. The hydrogen-deuterium exchanged mixture was then clarified by
centrifuging at 7000 g for 1 min at 4uC. The supernatant was divided into three
fractions, quickly frozen in liquid nitrogen, and stored at 280uC.
www.nature.com/scientificreports
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Mass spectrometry of the pepsin-digested protein samples was performed using
the 4800 Plus MALDI TOF/TOF Analyzer (Applied Biosystems, Foster City, CA).
In case any deuterium back-exchange occurred during the experiment, we
included control reactions where the exchange was carried out for 24 h at 25uC in
nIgG or H-ficolin alone and the data were calculated accordingly. The resulting
mass spectra were viewed and calibrated using the Data Explorer version 4.9
software (Applied Biosystems). The data were analyzed with reference to the
theoretical mass of the two prominent peptides in the spectra (theoretical m/z 5
932.42 and 1452.73). Peptide mass (average value) was calculated by determining
the centroid of its isotopic envelope using the Decapp software (University of
California San Diego, La Jolla, CA). The average number of deuterium atoms
incorporated in the peptide was calculated based on the difference between its
centroid values in the deuterated and non-deuterated samples. Hydrogen-
deuterium exchange at the side chains was determined to be in 4.5% of the
fast-exchanging side-chain hydrogen atoms based on the dilution factors. The
side-chain deuteration factor was corrected prior to the back-exchange correction
during data analysis. Kinetic graphs of deuterium incorporation in the peptides
were plotted with the best fit based on a single exponential model accounting for
deuterium atoms that were exchanged at a fast rate (mainly with the amide
hydrogen atoms that were exposed to the solvent) during the reaction. Graphs
with best fit were plotted using the GraphPad Prism version 5 (GraphPad
Software, San Diego, CA). The difference in deuterium incorporation in the
peptides between the individual protein (nIgG or H-ficolin) and the complex
(nIgG:H-ficolin), that were greater or lesser than 10%, were considered as
significant38.
Real-time biointeraction analysis. To demonstrate the interaction between
peptide and protein in real-time, we employed surface plasmon resonance (SPR)
analysis using the BIAcore 2000 instrument (BIAcore AB), as previously
described12. Briefly, we first immobilized the CM5 chip with 10 mg/ml GlcNAc-
BSA (Dextra Labs, UK) in 10 mM sodium acetate (pH 4.0) using the amine-
coupling chemistry, according to the manufacturer’s specifications. Next,
H-ficolin (200 nM) in running buffer was injected over the GlcNAc-immobilized
chip for 100 s (association) followed by buffer flow for 200 s (dissociation). To
characterize the binding of nIgG peptides to H-ficolin, separate second injections
of increasing concentrations of nIgG peptides were made under similar running
conditions. During the experiment, the flow rate was constantly maintained at
30 ml/min. The bound proteins were removed after one cycle by injecting 15 ml of
0.1 M NaOH (regeneration buffer).
We used specific buffers for simulating the ‘‘normal condition’’ with TBS buffer
(25 mM Tris, 145 mM NaCl, pH 7.4, 2.5 mM CaCl2) and the ‘‘infection-inflam-
mation condition’’ with MBS buffer (25 mM MES, 145 mM NaCl, pH 6.5, 2 mM
CaCl2). The SPR sensograms were analyzed by the BIAevaluation 3.2 software and
the KD (dissociation constant) was calculated using 151 Langmuir binding model.
The plots were finally made by overlaying the original binding curves (black) with
the 151 binding model fitted curves (red). Controls used for normalization were
obtained by injection of buffers alone instead of the proteins. The difference in the
value of the resonance unit before and after injection is a measure of the pepti-
de:protein interaction. The plots shown are representative of three independent
experiments.
Statistical analysis. For all the experiments, three replicates were performed per
sample/condition tested. Data are presented as mean 6 SEM of three independent
experiments. Differences between averages were analyzed by two-tailed Student’s t
test. Significance was set at p value of , 0.05. *p , 0.05; **p , 0.01; n.s. not
significant.
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